Trulieve Cannabis has launched a campaign to support veterans that will run throughout November as part of an ongoing initiative
High Tide has announced that it has successfully completed a restructuring of approximately $8.9 million of the company’s outstanding debt
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy
Kanabo Group plc (LSE: KNB), the patient-focused provider of digital health services and specialist medicines, including medicinal cannabis, is pleased
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy
As reported by Cannareporter. Avextra will move forward with a double-blind Phase 2 clinical trial for the use of cannabis in
Cantourage Group SE (hereinafter “Cantourage,” ISIN: DE000A3DSV01, www.cantourage.com), a leading European company for the production and distribution of medical cannabis,
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.